|
|
DF/HCC News
Understanding environmental and genetic factors in GI malignancies Whether you are currently studying gastrointestinal cancers or not, Charles Fuchs, MD, MPH (DFCI) may well try to recruit you as a member of the Gastrointestinal (GI) Malignancies Program at DF/HCC
Leveraging genetics and technology in EGFR-mutated lung cancer Activating mutations in the epidermal growth factor receptor (EGFR) occur in a unique subset of patients with non-small cell lung cancers (NSCLC)
Tissue Microarray and Imaging Core The Tissue Microarray and Imaging (TMI) Core is dedicated to the construction and evaluation of high-quality tissue microarrays and imaging techniques for cancer research
First melanoma trial to target KIT aberrations with imatinib The incidence of malignant melanoma is increasing by 4% every year — the highest of any cancer type
Pathology Specimen Locator Core The Pathology Specimen Locator (PSL) Core has developed and implemented a web-based, center-wide solution that enables investigators to identify, locate, and retrieve formalin-fixed, paraffin-embedded pathology specimens for translational research
Signaling network connects cancer types and collaborators What could have prompted the scientific director of the Center for Thoracic Cancers at MGH to cross over into colorectal cancer research? The answer lies in a signaling network that links the two cancer types
Twenty-one new members join DF/HCC Twenty-one individuals have recently joined DF/HCC
Displaying results 85 to 91 out of 184
|
